Jubilant Pharmova Share Price: Nuvama maintains ‘BUY’ rating despite montreal drag – Check target – Markets
Jubilant Pharmova Share Price: Shares of Jubilant Pharmova are likely to remain in focus after brokerage firm Nuvama Research reiterated its ‘BUY’ rating on the stock and set a 12-month share price target. Despite trimming near-term estimates due to challenges at the Montreal facility, the brokerage remains optimistic about the company’s long-term growth prospects, driven…
